PS
PFE icon

Portfolio Strategies’s Pfizer PFE Stock Holding History

Portfolio Strategies’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,729
Closed -$242K – 98
2024
Q1 		$242K Buy
+8,729
New +$242K 0.02% 132
2018
Q4 		– Sell
-1,927
Closed -$81K – 154
2018
Q3 		$81K Sell
1,927
-919
-32% -$35.4K 0.05% 57
2018
Q2 		$98K Sell
2,846
-274
-9% -$9.36K 0.07% 52
2018
Q1 		$105K Buy
3,120
+10
+0.3% +$344 0.08% 52
2017
Q4 		$107K Buy
+3,110
New +$106K 0.07% 59

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Portfolio Strategies's PFE Position: Q2 2024 in Review

Portfolio Strategies sold out of Pfizer (PFE) in Q2 2024, closing a stake of 8,729 shares — an estimated $242K sold.

Portfolio Strategies first reported a position in PFE in Q4 2017 and held it in 5 quarters. The position peaked at $242K in Q1 2024. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Portfolio Strategies reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Portfolio Strategies sold 8,729 Pfizer shares in Q2 2024, an estimated $242K.
  • Portfolio Strategies first reported a position in Pfizer in Q4 2017 and held it in 5 quarters.
  • Portfolio Strategies's Pfizer position peaked at $242K in Q1 2024.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Portfolio Strategies's 13F filing for Q2 2024, filed 12 Aug 2024.